FibroGen, Inc (FGEN) Social Stream



FibroGen, Inc (FGEN): $24.39

0.79 (+3.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

FIBROGEN INC (FGEN) Price Targets From Analysts

Use the tables below to see what analysts covering FIBROGEN INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $30 $14 $24.333 $19.98 21.79%
2021-12-22 9 $29 $14 $21.166 $19.98 5.94%
2022-01-06 9 $29 $14 $21 $19.98 5.11%
2022-01-13 8 $29 $14 $19.6 $19.98 -1.9%
2022-03-01 7 $29 $14 $19.6 $19.98 -1.9%
2022-03-02 7 $29 $13 $19.2 $19.98 -3.9%
2022-05-10 6 $25 $13 $16.75 $19.98 -16.17%
2022-05-11 6 $25 $9 $14.5 $19.98 -27.43%
2022-05-24 5 $25 $8 $13.2 $19.98 -33.93%
2022-08-08 7 $25 $8 $13.2 $19.98 -33.93%
2022-10-14 7 $25 $8 $14.4 $19.98 -27.93%
2022-11-08 7 $25 $8 $15 $19.98 -24.92%
2022-11-09 7 $23 $9 $16.4 $19.98 -17.92%
2022-12-15 7 $23 $9 $16.2 $19.98 -18.92%
2022-12-20 7 $23 $9 $15.8 $19.98 -20.92%
2023-01-05 7 $27 $9 $17.6 $19.98 -11.91%

The Trend in the Analyst Price Target


Over the past 21 months, FGEN's average price target has gone down $22.97.

FGEN reports an average of 21.27% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-11 7 25 9 14.5 9.77 48.41%
2022-08-13 7 25 8 14.4 14.49 -0.62%
2022-10-14 7 25 8 14.4 15.87 -9.26%
2022-11-08 7 25 8 15.0 14.15 6.01%
2022-12-20 7 23 9 15.8 14.37 9.95%

FGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 0 5 1 1 7

The Trend in the Broker Recommendations


Over the past 122 days, FGEN's average broker recommendation rating improved by 0.29.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • FGEN has a higher upside potential (average analyst target price relative to current price) than 150.93% of all US stocks.
  • In terms of how FIBROGEN INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1478.51% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, FIBROGEN INC's average analyst price target is greater than 410.03% of them.
  • FGEN has a higher number of analysts covering the stock than 1069.84% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FIBROGEN INC are XENE, TARO, and AKTX.

What is the outlook for FGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6315 seconds.